Clinical trial
Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
NCT00939874 is registered in ClinicalTrials.gov with St Vincent's Hospital, Sydney as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
- Lead sponsor
- St Vincent's Hospital, Sydney
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- April 30, 2014
- Enrollment
- 52 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, hiv infections, osteopenia, osteoporosis